# DAPSONE
> **ANDA213907** · Abbreviated New Drug Application (Generic) · Sponsor: TP ANDA HOLDINGS · Approved 2023-06-06
## Drug
- **FDA Application Number:** ANDA213907
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DAPSONE
- **Generic name:** DAPSONE GEL, 5%
- **Active ingredients:** DAPSONE
- **Dosage form:** GEL
- **Route:** TOPICAL
- **Marketing status:** Prescription
- **Sponsor:** TP ANDA HOLDINGS
- **Manufacturer:** Trupharma, LLC
- **First approval:** 2023-06-06
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213907)
---
*AI Analytics · CC0 1.0*